HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

J&J Consumer & Personal Care, Device Head Lenehan Appointed President

This article was originally published in The Rose Sheet

Executive Summary

Johnson & Johnson Worldwide Chairman, Medical Devices and Diagnostics Group James Lenehan, who also oversees the Consumer & Personal Care Group, was appointed president of the company Jan. 22

You may also be interested in...



J&J Skin Care Extensions To Fuel Momentum In 2002

Johnson & Johnson is expanding its skin care category with multiple product extensions under all four of its brands - Aveeno, Neutrogena, Clean & Clear and RoC, the company said

BabyCenter.com

Johnson & Johnson acquires online parenting resource for approximately $10 mil. from eToys. Web site offers healthcare products for babies and pregnant women, as well as advice to parents and expectant mothers. BabyCenter Web site also includes ParentCenter.com and British Web site BabyCentre.co.uk. J&J's baby and kids care U.S. business generated 10.7% sales increase to $321 mil. in 2000 (1"The Rose Sheet" Jan. 29, p. 9)

OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"

With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program

Latest Headlines
See All
UsernamePublicRestriction

Register

RS009980

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel